Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Prognostic value of intra-tumoral estradiol level determined
February 10th, 2005
The prognostic value of intra-tumor estradiol (E2) level has been determined in breast cancer patients. Although the intra-tumoral E2 level "is thought to be more closely related to the E2-inducible events such as progesterone receptor (PR) induction and tumor growth than the serum E2 level, prognostic significance of the intra-tumoral E2 level in breast cancer patients has yet to be studied," according to oncologists in Japan. In a study conducted by Y. Miyoshi and coauthors at Osaka University, "E2 level in tumor tissues obtained from 90 primary breast cancer patients was measured by the high-pressure liquid chromatography-radioimmunoassay method,"...
Source: Women's Health Weekly (2005-02-10)
|
